Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Consolidated Statement of Cash Flows

The following table is the reconciliation of the accounting standard that modifies certain aspects of the recognition, measurement, presentation and disclosure of financial instruments as shown on the Company’s consolidated statement of cash flows:


	March 31,
	2026		2025
Cash and cash equivalents	$	178,087	$	66,286
Restricted cash (included in prepaid and other assets)	656		-
Restricted cash (included in other long-term assets)	332		105
Total cash, cash equivalents and restricted cash	179,075		66,391

Schedule of Amortized Cost, Unrealized Gains and Losses and the Fair Value

The following table summarizes the amortized cost, unrealized gains and losses and the fair value at March 31, 2026 and December 31, 2025.


	Amortized Cost		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
March 31, 2026:
Money Market Funds included in Cash Equivalents	$	8,573	$	-	$	-	$	8,573




December 31, 2025:
Money Market Funds included in Cash Equivalents	$	4,805	$	-	$	-	$	4,805
Commercial Paper	3,694		-		-		3,694
Total December 31, 2025 short-term assets	$	8,499	$	-	$	-	$	8,499

Schedule of Carrying Value and Fair Value of Financial Assets

The following table provides the carrying value and fair value of the Company’s financial assets measured at fair value on a reoccurring basis as of March 31, 2026 and December 31, 2025:


	Carrying Value		Level 1		Level 2		Level 3
March 31, 2026:
Money Market Funds and Cash Equivalents	$	8,573	$	8,573	$	-	$	-




Marketable Equity Securities	6,818		6,818		-		-
Contingent Consideration liability	105,573		-		-		105,573
December 31, 2025:
Money Market Funds and Cash Equivalents	$	4,805	$	4,805	$	-	$	-
Commercial Paper	3,694		-		3,694		-
Total December 31, 2025 short-term assets	$	8,499	$	4,805	$	3,694	$	-
Marketable Equity Securities	10,364		10,364		-		-
Contingent Consideration liability	102,116		-		-		102,116